Northwestern Mutual Investment Management Company’s Sarepta Therapeutics SRPT Stock Holding History

Northwestern Mutual Investment Management Company’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-21,943	Closed	-$375K	–	891
2025 Q2	$375K	Buy	21,943 +704	+3%	+$30K	0.01%	812
2025 Q1	$1.36M	Buy	21,239 +10	+0%	+$1.05K	0.02%	415
2024 Q4	$2.58M	Buy	21,229 +71	+0.3%	+$8.7K	0.06%	173
2024 Q3	$2.64M	Buy	21,158 +61	+0.3%	+$8.43K	0.06%	167
2024 Q2	$3.33M	Buy	+21,097	New	+$2.71M	0.09%	106

Other funds holding SRPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Northwestern Mutual Investment Management Company's SRPT Position: Q3 2025 in Review

Northwestern Mutual Investment Management Company sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 21,943 shares — an estimated $375K sold.

Northwestern Mutual Investment Management Company first reported a position in SRPT in Q2 2024 and held it in 5 quarters. The position peaked at $3.33M in Q2 2024. 320 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

Northwestern Mutual Investment Management Company reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
Northwestern Mutual Investment Management Company sold 21,943 Sarepta Therapeutics shares in Q3 2025, an estimated $375K.
Northwestern Mutual Investment Management Company first reported a position in Sarepta Therapeutics in Q2 2024 and held it in 5 quarters.
Northwestern Mutual Investment Management Company's Sarepta Therapeutics position peaked at $3.33M in Q2 2024.
320 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Northwestern Mutual Investment Management Company's 13F filing for Q3 2025, filed 7 Nov 2025.